Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03778931 |
|---|---|
| Brief Title: | Phase 3 Trial of Elacestrant vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer (EMERALD) |
| First Submitted : | December 3, 2018 |
| First Submitted that Met QC Criteria : | December 14, 2018 |
| First Posted : | December 19, 2018 |
| Results First Submitted : | March 20, 2023 |
| Results First Posted with QC Comments : | April 13, 2023 |
| Results First Submitted that Met QC Criteria : | December 4, 2023 |
| Results First Posted : | December 5, 2023 |
| Last Update Submitted that Met QC Criteria : | March 27, 2024 |
| Last Update Posted : | March 29, 2024 |